RYTM - Rhythm Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RYTM (1649904)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
33 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2019-05-30
RYTMVan Der Ploeg Leonardus H.T.Chief Scientific OfficerS - Sale+OE$25.20-10,00042,339-19%-$252,050
DM
2019-05-28
RYTMVan Der Ploeg Leonardus H.T.Chief Scientific OfficerS - Sale+OE$25.42-15,00042,339-26%-$381,350
M
2019-03-15
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.09-10,290506,342-2%-$309,647
M
2019-03-13
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.06-9,288516,632-2%-$279,182
M
2019-02-26
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.04-2,449525,6170%-$73,571
M
2019-02-15
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.02-12,920528,066-2%-$387,886
D
2019-02-13
RYTMGottesdiener Keith MichaelCEO, PresS - Sale+OE$30.00-3,934540,986-1%-$118,020
M
2019-01-22
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.05-15,779544,920-3%-$474,176
2019-01-18
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.01-10,115560,699-2%-$303,551
2019-01-16
RYTMVan Der Ploeg Leonardus H.T.Chief Scientific OfficerS - Sale$30.00-20042,3390%-$6,000
2019-01-16
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.00-662570,8140%-$19,860
2018-12-03
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.00-563571,4760%-$16,890
2018-11-02
RYTMGottesdiener Keith MichaelCEO, PresS - Sale$30.08-16,500572,039-3%-$496,320
D
2018-11-02
RYTMVan Der Ploeg Leonardus H.T.Chief Scientific OfficerS - Sale+OE$30.09-38,00042,539-47%-$1,143,420
D
2018-09-25
RYTMVan Der Ploeg Leonardus H.T.Chief Scientific OfficerS - Sale+OE$29.80-31,80052,339-38%-$947,540
2018-05-22
RYTMOrbimed Advisors LLCSee Remarks, 10%S - Sale$30.43-19,5802,750,079-1%-$595,768
M
2018-05-18
RYTMOrbimed Advisors LLC10%S - Sale$30.88-131,6362,769,659-5%-$4,065,440
D
2017-10-10
RYTMMpm Bioventures V, L.P.10%P - Purchase$17.00+100,0002,696,392+4%+$1,700,000
D
2017-10-10
RYTMFoley ToddDir, 10%P - Purchase$17.00+100,0002,696,392+4%+$1,700,000
D
2017-10-10
RYTMViswanathan Ravi10%P - Purchase$17.00+550,0004,909,956+13%+$9,350,000
D
2017-10-10
RYTMSandell Scott D10%P - Purchase$17.00+550,0004,909,956+13%+$9,350,000
D
2017-10-10
RYTMMott David M10%P - Purchase$17.00+550,0004,909,956+13%+$9,350,000
D
2017-10-10
RYTMKerins Patrick J10%P - Purchase$17.00+550,0004,909,956+13%+$9,350,000
D
2017-10-10
RYTMBaskett Forest10%P - Purchase$17.00+550,0004,909,956+13%+$9,350,000
D
2017-10-10
RYTMBarris Peter J10%P - Purchase$17.00+550,0004,909,956+13%+$9,350,000
D
2017-10-10
RYTMBarrett M James10%P - Purchase$17.00+550,0004,909,956+13%+$9,350,000
D
2017-10-10
RYTMNew Enterprise Associates 13 LP10%P - Purchase$17.00+550,0004,909,956+13%+$9,350,000
D
2017-10-10
RYTMMeeker David PDirP - Purchase$17.00+25,000101,335+33%+$425,000
D
2017-10-10
RYTMPfizer Inc10%P - Purchase$17.00+40,0001,427,639+3%+$680,000
D
2017-10-10
RYTMIpsen, S.A.10%P - Purchase$17.00+20,0001,646,198+1%+$340,000
D
2017-10-10
RYTMOrbimed Advisors LLC10%P - Purchase$17.00+355,0002,901,295+14%+$6,035,000
D
2017-10-10
RYTMFlynn James EPossible Member of 10% Group, 10%P - Purchase$17.00+355,000937,010+61%+$6,035,000
D
2017-10-05
RYTMBaker Bros. Advisors LPFormer 10% ownerP - Purchase$17.00+885,0001,878,242+89%+$15,045,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top